Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-01-11 2:01 pm Sale | 13G | The Arena Group Holdings, Inc. AREN | STROME MARK E | 11,528,853 4.99% | -26,910,073![]() (-70.01%) | View |
2020-02-12 6:25 pm Purchase | 13G | The Arena Group Holdings, Inc. AREN | STROME MARK E | 38,438,926 15.6% | 32,554,163![]() (+553.19%) | View |
2019-02-14 4:20 pm Sale | 13G | Cue Biopharma, Inc. CUE | STROME MARK E | 790,612 3.9% | -358,277![]() (-31.18%) | View |
2018-10-04 6:10 pm Sale | 13G | The Arena Group Holdings, Inc. AREN | STROME MARK E | 5,884,763 18.4% | -86,976![]() (-1.46%) | View |
2018-06-26 4:09 pm Purchase | 13G | The Arena Group Holdings, Inc. AREN | STROME MARK E | 5,971,739 19.4% | 5,971,739![]() (New Position) | View |
2018-05-25 4:28 pm Purchase | 13D | ZIVO Bioscience, Inc. ZIVO | STROME MARK E | 40,750,000 27.5% | 40,750,000![]() (New Position) | View |
2018-05-01 4:48 pm Sale | 13G | Pulse Biosciences, Inc. PLSE | STROME MARK E | 440,103 2.7% | -724,726![]() (-62.22%) | View |